CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 71 filers reported holding CHEMOCENTRYX INC in Q1 2016. The put-call ratio across all filers is 9.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,361,000 | +637.2% | 278,005 | +253.7% | 0.01% | +800.0% |
| Q2 2022 | $1,948,000 | +47.5% | 78,606 | +49.1% | 0.00% | 0.0% |
| Q1 2022 | $1,321,000 | -32.1% | 52,705 | -1.4% | 0.00% | 0.0% |
| Q4 2021 | $1,946,000 | +99.4% | 53,453 | -6.3% | 0.00% | – |
| Q3 2021 | $976,000 | -43.6% | 57,063 | -55.8% | 0.00% | -100.0% |
| Q2 2021 | $1,729,000 | -66.6% | 129,173 | +27.7% | 0.00% | -66.7% |
| Q1 2021 | $5,182,000 | -19.8% | 101,126 | -3.1% | 0.00% | -25.0% |
| Q4 2020 | $6,461,000 | +6.3% | 104,342 | -5.9% | 0.00% | 0.0% |
| Q3 2020 | $6,078,000 | -14.0% | 110,905 | -9.7% | 0.00% | -20.0% |
| Q2 2020 | $7,067,000 | +540.7% | 122,805 | +347.6% | 0.01% | +400.0% |
| Q1 2020 | $1,103,000 | +86.0% | 27,439 | +82.6% | 0.00% | – |
| Q4 2019 | $593,000 | -50.5% | 15,023 | -91.5% | 0.00% | -100.0% |
| Q3 2019 | $1,198,000 | -0.2% | 177,036 | +36.8% | 0.00% | 0.0% |
| Q2 2019 | $1,201,000 | -25.3% | 129,386 | +11.7% | 0.00% | 0.0% |
| Q1 2019 | $1,607,000 | +74.9% | 115,826 | +37.3% | 0.00% | 0.0% |
| Q4 2018 | $919,000 | -65.3% | 84,345 | -59.7% | 0.00% | 0.0% |
| Q3 2018 | $2,648,000 | +20.0% | 209,521 | +25.0% | 0.00% | 0.0% |
| Q2 2018 | $2,207,000 | +319.6% | 167,677 | +332.8% | 0.00% | – |
| Q1 2018 | $526,000 | -52.8% | 38,739 | -79.3% | 0.00% | -100.0% |
| Q4 2017 | $1,115,000 | -52.4% | 187,538 | -40.6% | 0.00% | -50.0% |
| Q3 2017 | $2,341,000 | -7.4% | 315,882 | +16.9% | 0.00% | 0.0% |
| Q2 2017 | $2,527,000 | +76.8% | 270,291 | +37.6% | 0.00% | +100.0% |
| Q1 2017 | $1,429,000 | +1.5% | 196,471 | +3.2% | 0.00% | 0.0% |
| Q4 2016 | $1,408,000 | -11.4% | 190,404 | -27.7% | 0.00% | 0.0% |
| Q3 2016 | $1,589,000 | +73.5% | 263,299 | +28.8% | 0.00% | 0.0% |
| Q2 2016 | $916,000 | +301.8% | 204,444 | +122.2% | 0.00% | – |
| Q1 2016 | $228,000 | -51.2% | 92,015 | +58.9% | 0.00% | – |
| Q4 2015 | $467,000 | -13.0% | 57,902 | -35.1% | 0.00% | – |
| Q3 2015 | $537,000 | +57.0% | 89,173 | +113.6% | 0.00% | – |
| Q2 2015 | $342,000 | +8450.0% | 41,741 | +6411.9% | 0.00% | – |
| Q1 2015 | $4,000 | -98.9% | 641 | -98.8% | 0.00% | – |
| Q4 2014 | $362,000 | +306.7% | 53,183 | +165.6% | 0.00% | – |
| Q3 2014 | $89,000 | -76.4% | 20,023 | -69.1% | 0.00% | – |
| Q2 2014 | $377,000 | -61.3% | 64,878 | -55.9% | 0.00% | -100.0% |
| Q1 2014 | $975,000 | +34.9% | 147,158 | +17.6% | 0.00% | 0.0% |
| Q4 2013 | $723,000 | +72.1% | 125,088 | +65.0% | 0.00% | – |
| Q3 2013 | $420,000 | – | 75,821 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |